Assignment of Patents and Trademarks



 Exhibit 10.6 
 ASSIGNMENT OF PATENTS AND TRADEMARKS 
 WHEREAS, QLT USA, Inc., a Delaware corporation, with offices at 2579 Midpoint Drive, Fort Collins, CO 80525 (“ASSIGNOR”), owns certain patent applications and/or registrations, as listed in
Exhibit A attached hereto and incorporated herein by this reference (“PATENTS”), and trademarks, including applications and registrations, as listed on Exhibit B attached hereto and incorporated herein by
this reference (the “MARKS”); and 
 WHREAS, Arius Two, Inc., a Delaware corporation, with offices at 2501 Aerial Center
parkway, Suite 205, Morrisville, North Carolina 27560 (“ASSIGNEE”), desires to acquire all of the right, title and interest in, to and under the PATENTS and to the MARKS in accordance with the terms of that certain Intellectual
Property Assignment Agreement dated August 2, 2006 (the “Transfer Agreement”); 
 NOW, THEREFORE, in consideration of
the sum of One Dollar ($1.00) and other good and valuable consideration paid by ASSIGNEE to ASSIGNOR, the receipt and sufficiency of which hereby is acknowledged, ASSIGNOR does hereby: (1) sell, assign, transfer and convey unto ASSIGNEE all
right, title and interest in and to the PATENTS, including all divisions, continuations, continuations-in-part, reexaminations, substitutions, reissues, extensions and renewals of the applications and registrations for the PATENTS (and the right to
apply for any of the foregoing); all rights to causes of action and remedies related thereto (including, without limitation, the right to sue for past, present or future infringement, misappropriation or violation of rights related to the
foregoing); and any and all other rights and interests arising out of, in connection with or in relation to the PATENTS, and (2) transfer, convey and assign to ASSIGNEE all right, title and interest throughout the world (excluding the United
States of America, its territories and possessions (including the Commonwealth of Puerto Rico)) in and to the MARKS, together with all goodwill associated therewith, effective upon ASSIGNOR’S receipt of all payments due hereunder. 

In the event of any conflict or inconsistency between the terms of the Transfer Agreement and the terms hereof, the terms of the Transfer Agreement
shall govern. 
 IN WITNESS WHEREOF, ASSIGNOR has caused this Assignment
to be duly executed by an authorized officer on this 2nd day of August, 2006. 
  

			
	By:	 	 /s/ Michael R. Duncan

	Name:	 	Michael R. Duncan, President








 EXHIBIT A 
 COMPANY PATENT RIGHTS 
 NON-US 
  

									
	 Filing Date
	  	 Appl. Ser./Pub. Nos.
	  	Country/Status	  	 Title
	  	Priority
	Oct 16 1997	  	 PCT/US97/18605
 WO 1998/17251
(PCT of US 08/734,519)
  
 (334WO1)
	  	PCT – completed	  	Pharmaceutical Carrier Device Suitable for Delivery of Pharmaceutical Compounds to Mucosal Surfaces	  	US 08/734,519
(Oct. 18, 1996)
					
	Oct 16, 1997	  	 AU 97/47574
 (Nat’l stage of
 PCT/US97/18605)
  
 (334AU1)
	  	AUPN: 729516
Issued: May 17, 2001
Expires: Oct 16, 2017	  	Pharmaceutical Carrier Device ...Mucosal Surfaces	  	US 08/734,519
(Oct. 18, 1996)
					
	Apr 26, 2001	  	 AU 2001/38924
 (DIV of AU 97/47574)
  
 (334UA2)
	  	AUPN: 769500
Issued: May 13, 2004
Expires: Oct 16, 2017	  	Pharmaceutical Carrier Device ...Mucosal Surfaces	  	US 08/734,519
(Oct. 18, 1996)
					
	Apr 26, 2001	  	 CA 2268187
 (Nat’l stage of
 PCT/US97/1/18605)
  
 (334CA1)
	  	Canada - pending	  	Pharmaceutical Carrier Device ...Mucosal Surfaces	  	US 08/734,519
(Oct. 18, 1996)
					
	Apr 26, 1997	  	 EP97910117.7
 (Nat’l stage of
 PCT/US97/1/18605)
  
 (334EP1)
	  	EPPN: 0973497
Issued: Dec 11, 2002
Expires: Oct 16, 2017  
 Also issued
in
Austria, Belgium,
Denmark, France,
Germany, Greece,
Ireland, Italy,
Netherlands, Spain,
Sweden, Switzerland,
and United Kingdom
	  	Pharmaceutical Carrier Device ...Mucosal Surfaces	  	US 08/734,519
(Oct. 18, 1996)
					
	Oct 16, 1997	  	 JP 10-519467
 (Nat’l stage of
 PCT/US97/1/18605)
  
 (334EP1)
	  	Japan – pending	  	Pharmaceutical Carrier Device ...Mucosal Surfaces	  	US 08/734,519
(Oct. 18, 1996)
					
	Oct 16, 1997	  	 JP 200518632
 (DIV of JP 10-519467)
  
 Pubn No. 2005-281322 Published Oct 13, 2005 (334JP2)
	  	Japan - pending	  	Pharmaceutical Carrier Device ...Mucosal Surfaces	  	US 08/734,519
(Oct. 18, 1996)









									
	 Filing Date
	  	 Appl. Ser./Pub. Nos.
	  	Country/Status	  	 Title
	  	Priority
	Apr 29, 1999	  	 PCT/US99/09378 WO 99/55312 (PCT of US 09/069,703)
  
 (335WO1)
	  	PCT – completed	  	Pharmaceutical Carrier Device ...Mucosal Surfaces	  	US 08/734,519
(Oct 18, 1996)
US 09/069,703
(Apr. 29, 1998)
					
	Apr 29, 1999	  	 AU 99/39678
 (Nat’l stage of
PCT/US99/09378)
  
 (335AU1)
	  	AUPN: 746339
Issued: Aug 1,
2002
Expires: Apr. 29,
2019	  	Pharmaceutical Carrier Device ...Mucosal Surfaces	  	US 08/734,519
(Oct 18, 1996)
US 09/069,703
(Apr. 29, 1998)
					
	Apr 29, 1999	  	 CA 2,329,128
 (Nat’l stage of
PCT/US99/09378)
  
 (335CA1)
	  	Canada – pending	  	Pharmaceutical Carrier Device ...Mucosal Surfaces	  	US 08/734,519
(Oct 18, 1996)
US 09/069,703
(Apr. 29, 1998)
					
	Apr 29, 1999	  	 EP 99922753.1
 (Nat’l stage of
PCT/US99/09378)
  
 (335EP1)
	  	EP 1079813
Issued: Feb 9, 2005
Expires: Apr.
29, 2019  
 Also issued in
Austria, Belgium,
Denmark, Finland,
France, Germany,
Greece, Ireland,
Italy,
Luxembourg,
Netherlands,
Portugal, Spain,
Sweden,
Switzerland, and
United Kingdom
	  	Pharmaceutical Carrier Device ...Mucosal Surfaces	  	US 08/734,519
(Oct 18, 1996)
US 09/069,703
(Apr. 29, 1998)
					
	Apr 29, 1999	  	 JP 2000545511
 (Nat’l stage of
PCT/US99/09378)
  
 (335JP1)
	  	Japan – pending	  	Pharmaceutical Carrier Device ...Mucosal Surfaces	  	US 08/734,519
(Oct 18, 1996)
US 09/069,703
(Apr. 29, 1998)
					
	Apr 29, 1999	  	 JP 2005233505
 (DIV of JP 2000545511)
  
 (335JP2)
	  	Japan – pending	  	Pharmaceutical Carrier Device ...Mucosal Surfaces	  	US 08/734,519
(Oct 18, 1996)
US 09/069,703
(Apr. 29, 1998)









									
	 Filing Date
	  	 Appl. Ser./Pub. Nos.
	  	Country/Status	  	 Title
	  	Priority
	Apr 11, 2003	  	 PCT/US 03/11313
 WO 03/086345
 (PCT of US 10/121,430)
  
 (237WO1)
	  	PCT – completed	  	Process for Loading a Drug Delivery Device	  	US 10/121,430
(Apr. 11, 2002)
					
	Aug 16, 2004	  	 PCT/US2004/026531
 WO 2005/016321
 (PCT of US 60/495,356)
  
 (309WO1)
	  	PCT – completed	  	Adhesive Bioerodible Transmucosal Drug Delivery System	  	US 60/495,356
(Aug 15, 2003)
					
	Aug 16, 2004	  	 AU 2004/264974
 (Nat’l stage of
 PCT/US2004/026531)
  
 (309AU1)
	  	Australia - pending	  	Adhesive Bioerodible Transmucosal Drug Delivery System	  	US 60/495,356
(Aug 15, 2003)
					
	Aug 16, 2004	  	 CA 2,535,846
 (Nat’l stage of
 PCT/US2004/026531)
  
 (309CA1)
	  	Canada - pending	  	Adhesive Bioerodible Transmucosal Drug Delivery System	  	US 60/495,356
(Aug 15, 2003)
					
	Aug 16, 2004	  	 EP 04781250.8
 (Nat’l stage of
 PCT/US2004/026531)
 Publ EP1660056
 Published May 31, 2006
  
 (309EP1)
	  	EP - pending	  	Adhesive Bioerodible Transmucosal Drug Delivery System	  	US 60/495,356
(Aug 15, 2003)
					
	Aug 16, 2004	  	 JP
 (Nat’l stage of
 PCT/US2004/026531)
  
 (309JP1)
	  	JP - pending	  	Adhesive Bioerodible Transmucosal Drug Delivery System	  	US 60/495,356
(Aug 15, 2003)
					
	Aug 16, 2004	  	 MX PA/a/2006/001776
 (Nat’l stage of
 PCT/US2004/026531)
  
 (309MX1)
	  	MX - pending	  	Adhesive Bioerodible Transmucosal Drug Delivery System	  	US 60/495,356
(Aug 15, 2003)








 SCHEDULE 1.22 
 COMPANY TRADEMARK RIGHTS 
 BEMA 
  

											
	 Country
	  	Application No. /
Filed Date	  	Registration No. /
Registration	  	Expiry /Renewal
Date	  	 Description/Comments
	  	Priority
	Australia	  	1028272 Nov
4, 2004	  	1028272
Apr 11, 2005	  	Nov 4, 2014
Nov 4, 2014	  	Cl. 05 - Polymer Film, namely, adhesive bandages for topical application of pharmaceuticals;
Cl. 10 - Polymer film for use as an applicator for pharmaceuticals	  	US 78/424675
May 25, 2004
						
	Japan	  	2004-107883
Nov 25, 2004	  	pending	  		  	CL 05, CL 10 - Polymer film, namely, adhesive bandages for topical application of pharmaceuticals	  	US 78/424675
May 25, 2004
						
	European Community OHIM	  	004097416
Nov 4, 2004	  	pending	  		  	Cl. 05 - Polymer Film, namely, adhesive bandages for topical application of pharmaceuticals;
Cl. 10 - Polymer film for use as an applicator for pharmaceuticals	  	US 78/424675
May 25, 2004